Welcome : Guest

PROTEOMICS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 75 companies including many key and niche players such as -

ActivX Biosciences, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Daltonics, Inc.
Caprion Biosciences, Inc.
Digilab, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-1029
Price: $4950
Companies: 75
Pages: 261
Date: March 2018
Market Data Tables: 51
  Status: * New Report



TABLE OF CONTENTS


  PROTEOMICS (Complete Report) Pages : 261   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Proteomics – The Current Spotlight.....II-1
Proteomics Market to Grow at a Phenomenal Rate.....II-1
2$200
   Proteomics: A Critical Drug Discovery Tool.....II-31$100
   Research to Dominate the Market in the Immediate Future.....II-4
The Stoller Biomarker Discovery Centre – Establishing the Most Comprehensive
  Proteomics Solutions.....II-4
1$100
   Proteomics Technologies: Growing in Significance.....II-51$100
   Proteomics Technological Developments and Innovations.....II-61$100
   New Technological Advancements.....II-7
Innovations in Proteomics.....II-7
1$100
   Personalized Medicine Market Driven by Constraints in Traditional Treatment
  Approach.....II-8
1$100
   Table 1: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart).....II-91$350
   Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic
  Area.....II-10
1$100
   Table 2: Leading Personalized Medicines Worldwide (2015-2017): Annual Sales of Select Leading Medicines in US$ Million (includes corresponding Graph/Chart).....II-11
Rising Investment in Proteomics R&D.....II-11
1$350
   Ballooning Global Population Offers Significant Growth Opportunities.....II-12
Table 3: World Population (In Million) for the Years 2018-2050 (includes corresponding Graph/Chart).....II-12
1$350
   Table 4: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (includes corresponding Graph/Chart).....II-131$350
   Aging Global Population Drives Proteomics.....II-14
Table 5: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-14
1$350
   Table 6: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-151$350
   Table 7: Global Population Statistics for the 60+ Age Group by Region (2017) (includes corresponding Graph/Chart).....II-16
Advancements in Proteomics Bring Biomarkers into Limelight.....II-16
1$350
   List of US-FDA Approved Biomarkers for Cancer.....II-171$100
   Oncology – A Key Focus Area for Proteomics.....II-18 1$100
   Table 8: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart).....II-191$350
   Table 9: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart).....II-201$350
   International Initiatives in the Proteomics Market.....II-21
China All Set To Play a Major Role in the Proteomics Industry.....II-21
1$100
   Global Proteomics Sample Preparation Market – On a Growth Curve.....II-22
Challenges Facing Proteomics Sample Preparation Market.....II-22
Industrialization of Proteomics Research Propels Sample Preparation
  Technologies.....II-22
1$100
   Factors Limiting Market Growth.....II-23
Market Restrains/Challenges.....II-23
Expensive Equipment.....II-23
Lack of Proficient Researchers.....II-23
Protein Chemistry and its Complexities.....II-23
Quantitation.....II-23
1$100
   Integration of Data & Equipment.....II-24
Data Validation – A Burning Issue.....II-24
Standardization & Consistency – A Prime Concern.....II-24
1$100
   Incomplete and Disorganized Data.....II-251$100
   A Highly Fragmented Market.....II-26
Proteomics Product and Service Suppliers.....II-26
1$100
   Tool Providers: Leading the Proteomics Market.....II-27
Role of Contract Research Organizations - All Set to Increase in Proteomics.....II-27
1$100
   Proteins, Proteome and Proteomics!!! – What are They?.....II-28
Proteomics – An Introduction.....II-28
1$100
   Genesis of Proteomics.....II-29
Tales from Times Gone By.....II-29
Components of Proteomics.....II-29
Expression Proteomics.....II-29
Functional Proteomics.....II-29
1$100
   Cell-map Proteomics.....II-30
Structural Proteomics.....II-30
Technologies and Proteomics.....II-30
Proteomics and Genomics.....II-30
Proteomics and Genomics: A Comparison.....II-30
1$100
   Protein Production Pathway: From Gene Expression to Functional Protein with
  Controls.....II-31
From Genomics to Proteomics.....II-31
1$100
   Functional Genomics and Proteomics.....II-32
Push from Genomic Information.....II-32
1$100
   An Insight into Proteomics Data Type and their Characteristics / Features.....II-33
Standard Proteomics Approach.....II-33
Sample Preparation – Step I.....II-33
Protein Separation – Step II.....II-33
1$100
   Protein Visualization.....II-34
Protein Expression Analysis-Step III.....II-34
Image Analysis – Identify differentially expressed spots.....II-34
Protein Identification – Step IV.....II-34
1$100
   Data Storage and Processing – Step V.....II-351$100
   A Snapshot of Various Proteomics Tools.....II-36
An Insight into Various Proteomics Technologies and their Application Areas.....II-36
Protein Separation.....II-36
2-Dimensional Gel Electrophoresis (2DGE).....II-36
1$100
   Elements of 2-DE Proteomics.....II-37
Two – Dimensional Differential Gel Electrophoresis.....II-37
Combining 2D Gel Electrophoresis with Mass Spectrometry (MS).....II-37
2D Capillary LC.....II-37
1$100
   Analytical Strength of LC-MS and MS/MS in Shotgun Protein Sequencing.....II-38
Protein Characterization.....II-38
Analysis of Protein through Mass Spectrometry.....II-38
MS and Proteins.....II-38
1$100
   Comparison of MS Techniques.....II-39
Applications of MS.....II-39
1$100
   Problems Associated with MS.....II-40
Types of Analyzers or Filters.....II-40
MALDI-TOF MS.....II-40
MS/MS.....II-40
SELDI-TOF.....II-40
1$100
   Laser Capture Microdissection.....II-41
Tandem MS.....II-41
Y2H, Yeast 2-Hybrid System.....II-41
Sensitivity of Two-Hybrid Assays.....II-41
1$100
   Limitations of Y2H.....II-42
Protein Microarrays.....II-42
Market Influencers in Protein Microarrays Market.....II-42
Chip Technology.....II-42
1$100
   Microfluidic Applications.....II-43
Role of Bioinformatics in Proteomics.....II-43
Bioinformatics Applications and Tools in Proteomics.....II-43
MS Programs.....II-43
1$100
   2- DE gel Comparison.....II-44
2-DE Databases.....II-44
Databases of 2D-electrophoretic maps.....II-44
1$100
   Emerging Proteomics Technologies.....II-45
MudPIT.....II-45
ICAT.....II-45
ICAT strategy: A solution to quantitative proteome analysis.....II-45
Phage Display Technique.....II-45
Advanced Proteomics Technologies: Structural Analysis Tools.....II-45
X-ray Crystallography.....II-45
1$100
   Nuclear Magnetic Resonance (NMR).....II-46
In silico Modelling.....II-46
1$100
   Physicochemical Factors Constraining Metabolic Functions.....II-471$100
   End-Use Application Areas.....II-481$100
   Proteomics in Drug Discovery and Diagnostics.....II-49
Proteomics and Drug Discovery.....II-49
1$100
   Protein Microarrays: A New Tool for the Development of Pharmaceuticals.....II-50
Proteomic Approaches Gain Prominence in Cancer Drug Discovery.....II-50
1$100
   Proteomics Technologies Used in Cancer Drug Discovery and Development.....II-511$100
   PharmaFluidics Introduces µPAC.....II-52
Bruker Introduces the timsTOF Pro System for PASEF Mass Spectrometry.....II-52
NanoString Introduces Genomics and Proteomics Research Products.....II-52
Waters Corp. Offers Proteolabels Software.....II-52
Gemini Biosciences Introduces New Proteomics and Antibody Services.....II-52
Waters Introduces a New Data Acquisition Mode, SONAR.....II-52
Genovis Introduces GingisREX.....II-52
1$100
   Proteomics International Partners with Dimerix.....II-53
SCIEX & NUS Faculty of Science Launches Training Centre for Proteomics and Mass
  Spectrometry.....II-53
ARCH Venture Partners & Versant Ventures Establish Vividion Therapeutics.....II-53
SYGNIS AG Acquires Expedeon Holdings.....II-53
1$100
   ActivX Biosciences, Inc. (USA).....II-54
Agilent Technologies, Inc. (USA).....II-54
1$100
   Bio-Rad Laboratories, Inc. (USA).....II-551$100
   Bruker Daltonics, Inc. (USA).....II-56
Caprion Biosciences, Inc. (Canada).....II-56
1$100
   Digilab, Inc. (USA).....II-57
GE Healthcare (United Kingdom).....II-57
1$100
   Geneva Bioinformatics S.A. (Switzerland).....II-58
Merck KGaA (Germany).....II-58
PerkinElmer, Inc. (USA).....II-58
1$100
   Shimadzu Corporation (Japan).....II-59
Millipore Sigma (USA).....II-59
1$100
   Thermo Fisher Scientific, Inc. (USA).....II-60
Waters Corp. (USA).....II-60
1$100
   Xencor, Inc. (USA).....II-611$100
   Table 10: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-621$350
   Table 11: World Historic Review for Proteomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-631$350
   Table 12: World 14-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart).....II-641$350
   Table 13: World Recent Past, Current & Future Analysis for Proteomics by Segment - Instruments, Reagents, and Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-651$350
   Table 14: World Historic Review for Proteomics by Segment - Instruments, Reagents, and Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-661$350
   Table 15: World 14-Year Perspective for Proteomics by Segment - Percentage Breakdown of Dollar Sales for Instruments, Reagents, and Services Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart).....II-671$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Personalized Medicine – A Major Driver for the Proteomics Market.....III-1
1$75
   Companies and Investors Bullish on Personalized Medicine Market in the US.....III-2
Government Agencies Push for Personalized Medicines.....III-2
FDA Approvals of Personalized Medicines Continue to Rise.....III-2
1$75
   FDA Approved Personalized Medicines: 2016 & 2017.....III-3
Cancer Presumes Epidemic Proportion in the US.....III-3
1$75
   Table 16: New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart).....III-41$200
   Table 17: Cancer Related Deaths by Gender and Affected Site in the US (2016) (includes corresponding Graph/Chart).....III-51$200
   Table 18: New Cancer Cases in the US by State (20176) (includes corresponding Graph/Chart).....III-61$200
   Proteomics to Provide POCT for Patients in Hospice Care.....III-7
Demographic Changes Offer Growth Opportunities.....III-7
Table 19: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-7
1$200
   Proteomics Sample Preparation Market.....III-8
Product Launches.....III-8
Strategic Corporate Developments.....III-8
1$75
   Select Key Players.....III-96$450
   B. Market Analytics.....III-15
Table 20: The US Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-15
1$200
   Table 21: The US Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
Rising Incidence of Chronic Diseases Spurs Proteomics Demand.....III-17
1$75
   Table 22: New Cancer Cases in Canada (2017E): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart).....III-181$200
   Table 23: New Cancer Cases in Canada by Province: 2017E (includes corresponding Graph/Chart).....III-191$200
   Table 24: New Cancer Cases in Canada by Age Group: 2017E (includes corresponding Graph/Chart).....III-201$200
   Table 25: Cancer Related Deaths in Canada (2017E): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart).....III-21
Caprion Biosciences Inc. – A Key Player (Canada).....III-21
1$200
   B. Market Analytics.....III-22
Table 26: Canadian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-22
1$200
   Table 27: Canadian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Demographics Drive Market Growth.....III-24
Table 28: Japanese Population by Age Group (2017E): Percentage Breakdown for 0-14 Years, 15-24 Years, 25-54 Years, 55-64 Years, 64 Years and Above (includes corresponding Graph/Chart).....III-24
Shimadzu Corp. – A Key Player.....III-24
1$200
   B. Market Analytics.....III-25
Table 29: Japanese Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-25
1$200
   Table 30: Japanese Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-261$200
   A. Market Analysis.....III-27
Proteomics Market in Europe.....III-27
Aging Population to Drive Demand for Proteomics.....III-27
1$75
   Table 31: EU-28 Country-wise Statistics of 65+ Population as % of Total Population: 2016 (includes corresponding Graph/Chart).....III-281$200
   Cancer Trends.....III-29
Table 32: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart).....III-29
European Personalized Medicine Market to Exhibit Robust Growth.....III-29
Europe Heading towards Massive Improvements in Personalized Medicine.....III-29
1$200
   Personalized Medicine Big on EU Agenda – A Peek into EC Investments in This
  Space.....III-30
Proteomics Research in Europe – An Overview.....III-30
1$75
   Protein Identification Market.....III-311$75
   Protein Separation Market.....III-32
Market Challenges.....III-32
Gaining Edge in the Proteomics Industry – Player Strategies.....III-32
1$75
   Select Key Players.....III-331$75
   B. Market Analytics.....III-34
Table 33: European Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-34
1$200
   Table 34: European Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-351$200
   Table 35: European 14-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Table 36: French Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-37
1$200
   Table 37: French Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Select Key Player – Merck KGaA (Germany).....III-39
1$75
   B. Market Analytics.....III-40
Table 38: German Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-40
1$200
   Table 39: German Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-411$200
   Market Analysis.....III-42
Table 40: Italian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-42
1$200
   Table 41: Italian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-431$200
   A. Market Analysis.....III-44
Highlights.....III-44
Increased Support for Personalized Medicine to Drive Proteomics Demand.....III-44
1$75
   Product Launch.....III-45
Strategic Corporate Development.....III-45
GE Healthcare (United Kingdom) – A Key Player.....III-45
1$75
   B. Market Analytics.....III-46
Table 42: The UK Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-46
1$200
   Table 43: The UK Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
Spain – Poised to become a Reckoning Force in Personalized Medicines.....III-48
Product Launches.....III-48
Key Player.....III-48
1$75
   B. Market Analytics.....III-49
Table 44: Rest of European Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-49
1$200
   Table 45: Rest of European Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Healthcare Spending in Asia-Pacific: On the Rise.....III-51
China.....III-51
Government Support Drives Personalized Medicine Market in China.....III-51
India.....III-51
Indian Scientific Research towards Functional Genomics and Proteomics.....III-51
1$75
   Product Launch.....III-52
Strategic Corporate Development.....III-52
1$75
   B. Market Analytics.....III-53
Table 46: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-53
1$200
   Table 47: Asia-Pacific Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 48: Latin American Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-55
1$200
   Table 49: Latin American Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-561$200
   Market Analysis.....III-57
Table 50: Rest of World Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-57
1$200
   Table 51: Rest of World Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-581$200
  
Total Companies Profiled: 75 (including Divisions/Subsidiaries - 79)

Region/Country Players

The United States 45 Canada 4 Japan 2 Europe 24 France 2 Germany 7 The United Kingdom 7 Rest of Europe 8 Asia-Pacific (Excluding Japan) 4
Click here to request a full table of contents and more details on this project.